quinidine has been researched along with Mood Disorders in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stahl, SM | 1 |
| Deeks, ED; Yang, LP | 1 |
| Olney, N; Rosen, H | 1 |
| Garnock-Jones, KP | 1 |
| Pioro, EP | 1 |
| Weintraub, D | 1 |
| Pope, LE; Schiffer, R | 1 |
| Miller, A | 1 |
| Smith, RA | 1 |
| Bonavita, V; Di Costanzo, A; Di Iorio, G; Mottola, A; Tedeschi, G; Toriello, A | 1 |
7 review(s) available for quinidine and Mood Disorders
| Article | Year |
|---|---|
Dextromethorphan/quinidine: a review of its use in adults with pseudobulbar affect.
Topics: Adult; Dextromethorphan; Drug Combinations; Humans; Mood Disorders; Nervous System Diseases; Quinidine | 2015 |
AVP-923, a combination of dextromethorphan hydrobromide and quinidine sulfate for the treatment of pseudobulbar affect and neuropathic pain.
Topics: Animals; Clinical Trials as Topic; Dextromethorphan; Diabetic Neuropathies; Drug Combinations; Humans; Mood Disorders; Quinidine | 2010 |
Dextromethorphan/quinidine: in pseudobulbar affect.
Topics: Amyotrophic Lateral Sclerosis; Crying; Dextromethorphan; Drug Combinations; Emotions; Female; Humans; Laughter; Male; Mood Disorders; Multiple Sclerosis; Quinidine | 2011 |
Current concepts in the pharmacotherapy of pseudobulbar affect.
Topics: Antidepressive Agents; Crying; Dextromethorphan; Drug Combinations; Humans; Laughter; Mood Disorders; Off-Label Use; Quinidine | 2011 |
Review of pseudobulbar affect including a novel and potential therapy.
Topics: Analgesics, Non-Narcotic; Cytochrome P-450 CYP2D6 Inhibitors; Dextromethorphan; Drug Therapy, Combination; Humans; Mood Disorders; Pseudobulbar Palsy; Quinidine | 2005 |
Pseudobulbar affect in multiple sclerosis: toward the development of innovative therapeutic strategies.
Topics: Adrenergic alpha-Antagonists; Dextromethorphan; Emotions; Excitatory Amino Acid Antagonists; Humans; Mood Disorders; Multiple Sclerosis; Quinidine | 2006 |
Dextromethorphan/quinidine: a novel dextromethorphan product for the treatment of emotional lability.
Topics: Affective Symptoms; Biological Availability; Dextromethorphan; Drug Therapy, Combination; Humans; Mood Disorders; Quinidine | 2006 |
1 trial(s) available for quinidine and Mood Disorders
| Article | Year |
|---|---|
Does abnormal neuronal excitability exist in myotonic dystrophy? II. Effects of the antiarrhythmic drug hydroquinidine on apathy and hypersomnia.
Topics: Anti-Arrhythmia Agents; Cross-Over Studies; Disorders of Excessive Somnolence; Double-Blind Method; Humans; Medical Records; Mood Disorders; Myotonic Dystrophy; Neurons; Quinidine; Sleep | 2000 |
2 other study(ies) available for quinidine and Mood Disorders
| Article | Year |
|---|---|
Mechanism of action of dextromethorphan/quinidine:comparison with ketamine.
Topics: Dextromethorphan; Drug Combinations; Excitatory Amino Acid Antagonists; Humans; Ketamine; Mood Disorders; Quinidine | 2013 |
Therapeutic options for emotional lability: current and emerging treatments.
Topics: Antidepressive Agents; Dextromethorphan; Drug Interactions; Humans; Mood Disorders; Pseudobulbar Palsy; Quinidine; Randomized Controlled Trials as Topic | 2005 |